11/27/2024
4:06 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2024
4:07 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2024
4:05 PM | Contineum Therapeutics (Subject)
Lorrain Daniel S. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
3:08 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:10 PM | Contineum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024
11:46 AM | Contineum Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G | |
08/14/2024
5:03 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/14/2024
11:46 AM | Contineum Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
11:19 AM | Contineum Therapeutics (Filer)
| Form 8-K/A | |
06/24/2024
3:20 PM | Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/24/2024
3:25 PM | Boyce Sarah (Reporting)
Contineum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
4:43 PM | Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/03/2024
4:46 PM | Contineum Therapeutics (Issuer)
Healy John Stephen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:53 PM | Contineum Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:54 PM | Brady Todd R. (Reporting)
Contineum Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:54 PM | Contineum Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:55 PM | Contineum Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:56 PM | Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:56 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:58 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:58 PM | Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
4:59 PM | Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:00 PM | Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
6:03 PM | Contineum Therapeutics (Issuer)
Ignelzi Troy A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
3:38 PM | Contineum Therapeutics (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G | |
04/15/2024
3:20 PM | Contineum Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
04/11/2024
5:10 PM | Contineum Therapeutics (Issuer)
Versant Side Fund IV, L.P. (Reporting)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2024
4:05 PM | Contineum Therapeutics (Issuer)
JOHNSON & JOHNSON (Reporting)
Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/10/2024
4:12 PM | Contineum Therapeutics (Subject)
JOHNSON & JOHNSON (Filed by)
| Form SC 13G | |
04/09/2024
3:49 PM | Contineum Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
3:47 PM | Contineum Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/05/2024
6:08 PM | Contineum Therapeutics (Filer)
| Form 424B4 | |
04/04/2024
11:14 PM | Contineum Therapeutics (Filer)
| Form EFFECT | |
04/04/2024
8:22 PM | Contineum Therapeutics (Issuer)
Versant Side Fund IV, L.P. (Reporting)
Versant Vantage I GP, L.P. (Reporting)
Versant Vantage I GP-GP, LLC (Reporting)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital IV, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Ventures IV, LLC (Reporting)
Versant Ventures VI GP, L.P. (Reporting)
Versant Ventures VI GP-GP, LLC (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:49 PM | Contineum Therapeutics (Issuer)
Stengone Carmine N. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:51 PM | Contineum Therapeutics (Issuer)
Lorrain Daniel S. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:52 PM | Contineum Therapeutics (Issuer)
Slover Peter T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:54 PM | Contineum Therapeutics (Issuer)
Huhn Stephen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:56 PM | Brady Todd R. (Reporting)
Contineum Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:58 PM | Contineum Therapeutics (Issuer)
Lyons-Williams Lori (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
4:59 PM | Contineum Therapeutics (Issuer)
Schimmelpennink Evert B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
04/04/2024
4:59 PM | Contineum Therapeutics (Issuer)
Ware Olivia C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/04/2024
1:09 PM | Contineum Therapeutics (Filer)
| Form CERT | |
04/01/2024
7:41 AM | Contineum Therapeutics (Filer)
| Form S-1/A | |
Free CTNM Stock Alerts